Advertise
NEWSLETTER
Genentech, Alector partner ...
Coya Therapeutics completes...
Alterity’s Parkinson’s drug...
Genflow presents interim re...
BodySpec opens body composi...
Genentech, Alector partner ...
Coya Therapeutics completes...
Alterity’s Parkinson’s drug...
Genflow presents interim re...
BodySpec opens body composi...
Bryan Johnson

Bryan Johnson’s Blueprint raises star-studded $60m funding round

Personal health revolution: How Bryan Johnson’s Blueprint could change your life

The intersection of AI and longevity: Bryan Johnson’s predictions for the next big investment wave

The intersection of AI and longevity: Bryan Johnson’s predictions for the next big investment wave

Could we really beat aging? Bryan Johnson’s controversial bet on longevity

Could we really beat aging? Bryan Johnson’s controversial bet on longevity

How Sinclair, Johnson, and Hyman reversed their biological age – and how you can too

How Sinclair, Johnson, and Hyman reversed their biological age – and how you can too

Bryan Johnson's Longevity Blueprint: Revolutionary Science or Expensive Fad?

Bryan Johnson’s Project Blueprint: Revolutionary science or expensive fad?

From 100 pills a day to LED baths: Bryan Johnson spends $2m a year to slow aging

What happens when longevity meets ideology?

Bryan Johnson joins Founders Longevity Forum London stellar line-up

The latest longevity science, investment, innovation and insight, delivered every morning.

Unlock Longevity Biotech Report for FREE

  • $617BN - Annual global revenue by 2045
  • $30BN+ - Invested in under 2 years
  • 3,036 - Therapeutics individually assessed